These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 1674319)

  • 1. Flecainide in cancer nerve pain.
    Lancet; 1991 Jun; 337(8753):1347. PubMed ID: 1674319
    [No Abstract]   [Full Text] [Related]  

  • 2. Analgesic effects of flecainide on postherpetic neuralgia.
    Ichimata M; Ikebe H; Yoshitake S; Hattori S; Iwasaka H; Noguchi T
    Int J Clin Pharmacol Res; 2001; 21(1):15-9. PubMed ID: 11708571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flecainide and cardiac dysrhythmias during dental extraction under anaesthesia.
    Clyburn PA; Fassoulaki A; Rosen M; Webster J
    Eur J Anaesthesiol; 1989 Jan; 6(1):39-48. PubMed ID: 2496977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Meta-analysis of flecainide safety in patients with supraventricular arrhythmias.
    Wehling M
    Arzneimittelforschung; 2002; 52(7):507-14. PubMed ID: 12189773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flecainide for the treatment of chronic neuropathic pain: a Phase II trial.
    von Gunten CF; Eappen S; Cleary JF; Taylor SG; Moots P; Regevik N; Cleeland C; Cella D
    Palliat Med; 2007 Dec; 21(8):667-72. PubMed ID: 18073252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flecainide for supraventricular tachyarrhythmias.
    Med Lett Drugs Ther; 1992 Jul; 34(875):71-2. PubMed ID: 1630411
    [No Abstract]   [Full Text] [Related]  

  • 7. Drugs for cardiac arrhythmias: new warning.
    Med Lett Drugs Ther; 1989 May; 31(792):48. PubMed ID: 2497313
    [No Abstract]   [Full Text] [Related]  

  • 8. The safety of flecainide treatment of atrial fibrillation: long-term incidence of sudden cardiac death and proarrhythmic events.
    Almroth H; Andersson T; Fengsrud E; Friberg L; Linde P; Rosenqvist M; Englund A
    J Intern Med; 2011 Sep; 270(3):281-90. PubMed ID: 21635583
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flecainide: its value and danger.
    Malik R; Ellenbogen KA; Stambler BS; Wood MA
    Heart Dis Stroke; 1994; 3(2):85-9. PubMed ID: 8199770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trials of flecainide acetate in the management of supraventricular arrhythmias.
    Camm AJ; Bashir Y
    Cardiologia; 1990 Mar; 35(3):193-7. PubMed ID: 2123129
    [No Abstract]   [Full Text] [Related]  

  • 11. [Psoriasis-like eruption caused by flecainide].
    Mancuso G; Tampieri E; Berdondini RM
    G Ital Dermatol Venereol; 1988 Apr; 123(4):171-2. PubMed ID: 2972607
    [No Abstract]   [Full Text] [Related]  

  • 12. [Severe proarrhythmic effects of flecainide].
    Frabetti F; Dattola L; Bellodi G; Padovani F
    Clin Ter; 1988 Oct; 127(1):43-7. PubMed ID: 2976341
    [No Abstract]   [Full Text] [Related]  

  • 13. Trial of flecainide acetate in the management of tinnitus.
    Fortnum HM; Coles RR
    Clin Otolaryngol Allied Sci; 1991 Feb; 16(1):93-6. PubMed ID: 1903336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Indications for flecainide.
    Jones K; Wood SM
    Lancet; 1989 Jun; 1(8651):1383. PubMed ID: 2567388
    [No Abstract]   [Full Text] [Related]  

  • 15. Flecainide-induced cardiogenic shock.
    Forbes WP; Hee TT; Mohiuddin SM; Hillman DE
    Chest; 1988 Nov; 94(5):1121. PubMed ID: 3141115
    [No Abstract]   [Full Text] [Related]  

  • 16. A double-blind crossover comparison of flecainide and slow-release mexiletine in the treatment of stable premature ventricular complexes.
    Capucci A; Di Pasquale G; Boriani G; Carini G; Balducelli M; Frabetti L; Carozzi A; Finzi A; Pinelli G; Magnani B
    Int J Clin Pharmacol Res; 1991; 11(1):23-33. PubMed ID: 1714885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flecainide: a new antiarrhythmic agent.
    Nestico PF; Morganroth J
    Am Fam Physician; 1986 Nov; 34(5):197-200. PubMed ID: 2430440
    [No Abstract]   [Full Text] [Related]  

  • 18. CAST and beyond. Implications of the cardiac arrhythmia suppression trials. By the Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
    Eur Heart J; 1990 Mar; 11(3):194-9. PubMed ID: 2108031
    [No Abstract]   [Full Text] [Related]  

  • 19. [Anomalies of the T waves induced by flecainide].
    Stoltz JP; Weingrod M; Leroy G; Halphen C; Haïat R
    Arch Mal Coeur Vaiss; 1988 Aug; 81(8):1009-12. PubMed ID: 3144249
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Oral flecainide in the treatment of refractory arrhythmias. Long-term follow-up of 98 patients].
    Haissaguerre M; Warin JF; Benchimol D; Le Métayer P; Regaudie JJ; Blanchot P
    Arch Mal Coeur Vaiss; 1987 Mar; 80(3):357-63. PubMed ID: 3113358
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.